<DOC>
	<DOCNO>NCT00211094</DOCNO>
	<brief_summary>The primary purpose study demonstrate dapoxetine prolong intravaginal ejaculatory latency time ( IELT ) compare placebo men premature ejaculation ( PE ) .</brief_summary>
	<brief_title>A Study Effectiveness Safety Dapoxetine Treatment Men With Premature Ejaculation</brief_title>
	<detailed_description>One form male sexual dysfunction premature ejaculation ( PE ) , also refer rapid ejaculation ( RE ) . The study consist 2 phase : pre-randomization phase ( screen visit 2-week baseline period ) ; 12-week double-blind treatment phase patient receive one 2 dos dapoxetine placebo use `` as-needed '' basis . The total duration study approximately 14 week . Assessments effectiveness include average intravaginal ejaculatory latency time ( measure stopwatch ) sexual intercourse , treatment period ; control ejaculation , participant partner satisfaction sexual intercourse , participant overall impression change severity symptom , base question ask monthly interval treatment phase . Safety assessment include incidence , severity , type adverse event study , ECGs , well laboratory test . At end baseline period , patient select study center undergo blood sample ECG monitoring first dose study medication . The study hypothesis treatment 12 week dapoxetine prolongs intravaginal ejaculatory latency time , compare placebo , men PE . Oral tablet dapoxetine ( 30 milligram [ mg ] 60mg ) placebo take need 12 week treatment . No 1 dose within 24-hour period .</detailed_description>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>Patient stable , monogamous sexual relationship woman least 6 month plan maintain relationship duration study history premature ejaculation 6 month study initiation due distress , interpersonal difficulty medication withdrawal history intravaginal ejaculatory latency time ( IELT ) &lt; = 2 minute least 3 4 event blood pressure &lt; = 180/100 mmHg screen end baseline patient partner must agree attempt sexual intercourse minimum interval specify protocol patient 's partner must negative urine pregnancy test time screen Not take dapoxetine previous investigational drug study use form therapy treatment PE ( behavioral therapy medication apply skin ) history medical event associate development PE take another investigational drug within 1 month history seizures major psychiatric disorder depression schizophrenia alcohol abuse dependence know allergy hypersensitivity dapoxetine selective serotonin reuptake inhibitor ( SSRIs ) partner decrease interest painful intercourse form sexual dysfunction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>dapoxetine</keyword>
	<keyword>premature ejaculation</keyword>
	<keyword>ejaculation</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>orgasmic disorder</keyword>
	<keyword>sexual intercourse</keyword>
</DOC>